Community/Retail

On this month's list of Rx products is an FDA-updated label for a cardiovascular disease drug, 2 FDA-approved NDAs for schizophrenia and alopecia areata, and an FDA approved treatment for pustular psoriasis.

The implementation of negative control outcomes and a complementary cohort demonstrate an estimated beneficial effect that associated with an individual’s overall health.

Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.

This issue's OTC Cases answer common questions about a cough.

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.

List of our November 2022 picks for generic products.

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.

Our Best Shot (OBS) is a new children’s book explaining why we should get an annual flu shot and it is not something to fear…and adults may even benefit, said the author.

Students should prepare to be preceptors early in their pharmacy school careers.

Findings support the potential protective association of vaccination in reducing long COVID, although it does not appear to eliminate the risk.

Children's books about the field of pharmacy are surprisingly scarce.

The objective of the study was to estimate recent trends in cigarette use and health insurance coverage for US adults with and without mental health and SUD.

Demand for treatment of anxiety and depression remained high for the third consecutive year as the demand for the treatment of trauma- and stressor-related and substance use disorders has increased.

Individuals with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those who did not have COVID-19 multiple times.

Both of Moderna's bivalent boosters showed neutralizing activity against BQ.1.1, an increasingly dominant emerging variant, confirming that updated vaccines have the potential to offer protection as the virus continues to evolve.

Teplizumab-mzwv is administered through injection and can delay the onset of type 1 diabetes in adults and pediatric patients.

Education and support inspire trust between patients and pharmacists.

Bepirovirsen produced sustained clearance of hepatitis B virus and hepatitis B surface antigens.

Dapagliflozin is the first SGLT2 inhibitor approved by the FDA for treatment of patients with heart failure (NYHA class II-IV) with reduced ejection fraction.

Patients administered 75 mg or higher of olpasiran every 12 weeks had a 95% or greater reduction in Lp(a) compared to placebo at week 36.

Five hours or less hours of sleep per night at 50 years of age was associated with a 25% higher risk of mortality over 25 years of follow-up.

Patients with Alzheimer disease administered gantenerumab did experience slower clinical decline, however, it was not deemed statistically significant.

There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.

Patients with this skin condition must make an ongoing commitment to their therapy regimen for best results.

Guselkumab (Tremfya) is a fully human selective IL-23 inhibitor therapy FDA-approved for the treatment of adults with active psoriatic arthritis and with moderate to severe plaque psoriasis.